- Continue Shopping
- Your Cart is Empty
Hexoskin wins contract to bring Astroskin sensors to the Moon
Montréal, November 26th, 2024
The Canadian Space Agency (CSA) has announced that it has awarded a contract to Hexoskin (Carré Technologies Inc.), a company based in Montreal, to develop and adapt the Astroskin Bio-Monitor crew physiological monitoring system for Gateway, a space station that will orbit the Moon.
The first two elements of Gateway – the Power and Propulsion Element (PPE) and the Habitation and Logistics Outpost (HALO) – are set to launch together in 2027.
The Astroskin Bio-Monitor has been in operation on the International Space Station (ISS) since January 2019, when it was commissioned by Canadian astronaut David Saint-Jacques. It is currently used in four clinical trials in space focused on studying the cardiorespiratory system and the accelerated aging effect of microgravity on human physiology.
Astroskin wearable sensors are sent to space on a regular basis, with 20 space payloads delivered to ISS so far, and a first suborbital flight completed in November 2023 with American astronaut Kellie Gerardi on Virgin Galactic’s mission 5.
More than 20 astronauts have used Astroskin wearable sensors for clinical research in microgravity, including astronauts from the USA, Canada, Japan, UAE, and Italy. (Photo credits: CSA, ESA, NASA, JAXA, Axiom/Mark Pathy, UAE Space Agency)
Astroskin wearable health sensors are also used by a large number of medical researchers around the world to study a wide number of health conditions, from hypertension to sleep quality, in clinical trials, and for defense and aerospace applications.
About Hexoskin, Space Medicine, and Clinical Research
Hexoskin has been involved in space medicine since its first contract with CSA in 2011. The investment from CSA in space medicine research has been a major driver of growth in the early development of the company, during the development of the Hexoskin and Astroskin wearable sensor platforms. Hexoskin has supported hundreds of clinical research projects since, leading to over 250 peer-reviewed scientific publications, patents, and novel AI software for clinical applications, with a focus on cardiac and respiratory diseases. Hexoskin participated in the first cohort of the ASU/Mayo Clinic Medtech accelerator in 2019.
More info on the Gateway contract awarded to Hexoskin:
https://www.nasa.gov/mission/gateway/
More info on Astroskin:
https://www.hexoskin.com/astroskin
Hexoskin @ HITLAB New York City Health Innovation Week
This week Hexoskin was participating in HITLAB's New York City Health Innovation Week in Manhattan. The event was attended by dozens of startups and large life science companies such as Merck, Novo Nordisk, and Sanofi.
To learn more about Hexoskin's involvement in pharma trials and clinical research, please write us at: contact@hexoskin.com
OneView Clinical Research Software Overview
Hexoskin OneView is a clinical software platform that allows health professionals and researchers to design their own protocols and easily monitor their projects and studies.
Our community uses it to collect data from patients in occupational wellness programs, rehabilitation programs, and clinical trials.
Participants can use an app to follow a program's calendar, complete questionnaires and enter all kinds of data you need to track their progress and monitor the performance of your project.
On top of that, you'll find it easy to:
-
manage cohorts and calendars
-
monitor data quality and compliance
-
use study templates, standardized questionnaires and health reports
-
easily clone protocols to create new study arms or health programs
-
use the sizing tool to pick the right size shirt to onboard participants
-
export all data to other systems like Excel, R and SAS for biostatistics
- the tools are available for Astroskin too!
Contact our team to see how we can support your program or study and access a free trial. We offer turnkey services for a wide range of projects, from protocol planning and design, to recruitment and study support, to biostatistics and endpoints.
Hexoskin @ 2024 JP Morgan Conference
Hexoskin will be in San Francisco again this year during the 42nd Annual J.P. Morgan Healthcare Conference, the largest life sciences investment event in the world.
We'll take the opportunity to meet with our clients and partners who use the Hexoskin software platform and wearables to advance our knowledge of human physiology.
We'll also present our new Hexoskin OneView platform for research and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.
Contact us to book a meeting: contact@hexoskin.com
Hexoskin @ HITLAB Innovators Summit 2023
This November at the HITLAB Innovators Summit at Columbia University in NYC we officially launched our new Hexoskin OneView platform for clinical research! For a long time we knew there was a need for better software to support digital biomarker development and clinical research with medical wearables.
We understand the needs of research organizations and clinical sites when it comes to onboarding participants, monitoring compliance and data quality.
So we did something about it.
OneView is the best solution for doing clinical research with Hexoskin and Astroskin wearables. It allows you to:
- Manage cohorts and calendars
- Monitor data quality and compliance
- Use study templates, standardized questionnaires and data reports
- Easily clone studies to create new study arms
- Export all data to other systems like R and SAS for biostatistics
The platform also includes a mobile app for patient reported outcomes and participant tasks management.
On top of that, Hexoskin offers turnkey services for clinical trials: protocol planning and design, recruitment, study support, biostatistics and endpoints, etc.
OneView is already used today by a select group of research organizations and Pharma companies - who joined our beta program earlier this year - to run clinical trials with a decentralized or virtual component. Their feedback has been amazing and has helped us improve OneView to make it an essential research tool.
Please visit our website: hexoskin.com/oneview to learn more about digital tools for clinical research.
The recording from the event is available below:
Hexoskin at Biosensors for Medical Wearables 2023 in Boston: Non-adhesive, flexible wearable sensors for pulmonary medical applications
Hexoskin's co-founder and CEO Pierre-Alexandre Fournier has been invited this year again to talk about wearable vital signs monitoring and digital biomarker development at the Biosensors for Medical Wearables Conference in Boston, this October 23rd.
Vital signs sensors traditionally used for cardiac and respiratory monitoring involve adhesives or tape to keep sensors in place on the skin. Experience has shown there's a tradeoff between monitoring duration (1 to 14 days), and adhesive agressiveness, which can lead to skin rashes or wounds.
There's now a safer and more convenient way for patients to record long-term vital signs data needed for diagnosis or digital biomarker development: smart textiles. Hexoskin users have successfully demonstrated the advantages of using a form factor that patients like. Researchers have documented it in over 200 scientific papers.
Moreover, Hexoskin biometric shirts' respiratory sensors allow continuous pulmonary measurements previously hard or impossible to collect in real-world situations, outside laboratory environments. These sensors open a new era of research on diseases that have an impact on the pulmonary function.
In his talk, Fournier will describe medical applications of smart textile sensors for patients with respiratory diseases, as well as opportunities in research in cardiology, mental health and rare diseases. He will also share unique insights into Hexoskin's experience in space medicine research aboard the International Space Station.
Please reach out for more information: contact@hexoskin.com
HITLAB Digital Health Summit 2023 - Hexoskin Video
Our CEO Pierre-Alexandre Fournier presented some of Hexoskin's efforts to solve the evidence gap for healthcare and clinical trials at Columbia University last month, and HITLAB recently made the 15 minutes video available online below.
Clinical evidence is what makes medical discoveries possible: that's how we measure safety and efficacy, and that's how we measure efficiency gains in healthcare delivery. When we lower the cost of evidence, we make care more accessible and affordable. This is an important part of our mission at Hexoskin.
In the video you'll see a few examples of our work at Hexoskin, from clinical research to AI development to human spaceflight.
The Hexoskin and Astroskin platform has been used to collect health data for over 200 scientific publications. White papers about wearable sensors applications for health monitoring of are available upon request.
Hexoskin and Halo Health to solve key challenges of clinical trials.
Hexoskin and Halo Health are announcing today a collaboration to solve key challenges in running clinical trials. Combining Hexoskin and Halo Health's technology will offer greater operational efficiency for virtual clinical trials and home monitoring, and offer tools to increase patient engagement.
These new tools will reduce the cost of collecting vital signs data for clinical trials, and will allow patients to participate in medical research from the comfort of their home.
Hexoskin smart garments and its Connected Health Platform are compatible with Halo Health solutions. The two companies will mutually promote their offering to pharmaceutical sponsors to support clinical development.
Halo Health is enabling patient-centric trials to reduce patient and site burden. Its Smart Clinical Trials solution is a digital health platform that provides Remote Patient Monitoring, Patient Engagement, and Workflow Automation. The solution includes an integrated ecosystem of clinical grade sensors and wearables to enable hybrid & virtual trials for various therapeutic areas including cardiology, respiratory and endocrinology.
Pierre-Alexandre Fournier - Chief Executive Officer at Hexoskin: “Medicine's progress depends on being able to better observe patients' outcomes. Anything we can do to lower the cost of data helps accelerate clinical development. This is something that Pharma and Biotech companies need to innovate, but most importantly this is something that we need to do to improve treatments for patients and find new cures for diseases that affect millions of people and their families.” says Pierre-Alexandre Fournier, Chief Executive Officer at Hexoskin. “Combining Halo Health's software with Hexoskin sensors and algorithms reduces the cost of collecting data in clinical trials, with greater flexibility & patient centricity.”
Hexoskin is a pioneer and leader in non-invasive vital signs sensors and remote patient monitoring solutions. Hexoskin Smart Clothing for Men, Women, and Children are clinically validated and its Connected Health Platform is used for health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.
We’re attending #DPHARM2019 in #Boston, at HaloHealth's Kiosk on September 17 & 18, 2019! Visit Booth 30 to learn about our joint innovative solutions to solve the key challenges of Clinical-trials!
Contact Hexoskin to learn more.
Live Webinar - Join us on May 30, 2018 at 12PM (EST) for a Live Webinar on Respiratory Monitoring!
The Hexoskin Connected Health Platform is used by researchers in many domains all around the world. Remote & Continuous Respiratory Monitoring is a field of interest that is gaining momentum, but few non-invasive solutions exist to monitor the lung function of subjects and patients.
We invite you to our second webinar that will cover our latest results and applications in respiratory research. We will also present how Hexoskin can monitor COPD patients by using its very unique physiological data.
Webinar: Remote & Continuous Respiratory Monitoring with Hexoskin
30 May 2018, at 12:00 PM (EST) - via the Zoom Video Conferencing software
Speaker: Thu Ngan Trinh, PhD, Clinical Application Specialist at Hexoskin
Guest Speaker: Ruud van Leuteren, MSc, PhD Candidate in Neonatology at the Academic Medical Centre in Amsterdam.
If you are unable to attend, we still invite you to register and we will send you the recorded webinar by email afterward.
We look forward to your presence at this new webinar!
About Hexoskin
Founded in 2006, Hexoskin has designed a system to minimize user setup time and to maximize vital signs monitoring over long periods in a non-obstructive way with sensors embedded in a Smart Shirt. Data are synced to local and remote servers for health data management and analysis. Hexoskin offers a non-invasive solution for longitudinal studies in cardiology, respiratory, sleep, CNS, activity, stress and mental illness.
Meet us at BIO in Boston on June 4-8, 2018!
Hexoskin will be attending the BIO International Convention in Boston, June 4-7, 2018 for its second year! The Smart Clothing industry's leader will present its new clinically validated collection of Smart Garments for clinical research. Hexoskin will also showcase the Hexoskin Smart, the best health monitor for continuous cardiac, respiratory, activity and sleep tracking. Hexoskin will also unveil a new solution to manage clinical trials and report real-world evidence with Machine Learning & AI. Come meet us!
View full article →